Investigating immunotherapies for endometrial cancer: Working as a MDT to identify patients and improve outcomes - Part 3
Listen to key experts from a multidisciplinary team discuss how patients with endometrial cancer should be tested to determine suitability for PD-1/PD-L1 inhibitor therapy.
The multidisciplinary team
- Gynaecological oncologist: Prof. Nicole Concin
- Pathologist: Dr Alicia León-Castillo
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from GlaxoSmithKline. This medical education is provided by touchIME.
For further information visit: https://touchoncology.com/education/mdt-for-io-in-ec/